Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 4, 2010, Pages 437-441

  Tassie, Jean Michel ^a   Baijal, Parijat ^a   Vitoria, Marco A ^a   Alisalad, Abdikamal ^a   Crowley, Siobhan P ^a   Souteyrand, Yves ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

antiretroviral therapy; monitoring; national programs; resource limited settings; retention; survival

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ANTIVIRAL THERAPY; ARTICLE; CHILD; DEVELOPING COUNTRY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; TREND STUDY; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASIA; CENTRAL AMERICA; ECONOMICS; EUROPE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; INCOME; MIDDLE EAST; POVERTY; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ASIA; CARIBBEAN REGION; EUROPE; FOLLOW-UP STUDIES; INCOME; MIDDLE EAST; POVERTY; TIME FACTORS;

EID: 77955503452     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181d73e1b     Document Type: Article

References (19)

1. World Health Organisation and UNAIDS. Treating 3 Million by 2005: Making It Happen. Geneva, Switzerland: WHO. 2003
2. WHO, UNAIDS, UNICEF. Toward Universal Access. Scaling Up Priority HIV/AIDS Interventions in the Health Sector. Progress Report. Geneva, Switzerland: WHO; 2009.
3. Mahy H, Tassie J-M, Ghys P, et al. Estimation of ART coverage: methodology and trends. Curr Opin HIV AIDS. 2010;5:97-102.
4. UNAIDS. Monitoring the Declaration of Commitment on HIV/AIDS\Guidelines on Construction of Core Indicators 2010 Reporting. Geneva, Switzerland: UNAIDS; 2009.
5. WHO, UNAIDS, PEPFAR, USAID. Patient Monitoring Guidelines for HIV Care and Antiretroviral Therapy. Geneva, Switzerland: WHO; 2006.
6. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009;4:e5790.
7. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4: e298.
8. Bussmann H, Wester CW, Ndwapi N, et al. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. AIDS. 2008;22:2303-2311.
9. Boulle A, Bock P, Osler M, et al. Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ. 2008;86:678-687.
10. Chasombat S, McConnell MS, Siangphoe U, et al. National expansion of antiretroviral treatment in Thailand, 2000-2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr. 2009;50:506-512.
11. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367:817-824.
12. Lawn SD, Harries AD, Anglaret X, et al. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-1908.
13. Nash D, Katyal M, Brinkhof MW, et al. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies. AIDS. 2008;22:2291-2302.
14. Fisher M. Late diagnosis of HIV infection: major consequences and missed opportunities. Curr Opin Infect Dis. 2008;21:1-3.
15. Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. 2008;13:870-879.
16. Bartlett JA, Shao JF. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis. 2009;9:637-649.
17. Souteyrand YP, Collard V, Moatti JP, et al. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries. AIDS. 2008;22(Suppl 1):S161-S168.
18. Posse M, Meheus F, van AH, et al. Barriers to access to antiretroviral treatment in developing countries: a review. Trop Med Int Health. 2008; 13:904-913.
19. Walker AS, Ford D, Ssali F, et al. Does cotrimoxazole prophylaxis improve outcomes after ART initiation in HIV-infected African adults? A causal analysis using marginal structural models. Presented at: 15th Conference on Retroviruses and Opportunistic Infections; February 3-6, 2008; Boston, MA.